Celltrion leads biosimilars deals landscape in South Korea, finds GlobalData
Celltrion dominates South Korea’s biosimilars landscape, driving deal-making and shaping the global market
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Celltrion
Celltrion signs COVID-19 antibody therapy supply deals with Europe
The first batch of 50,000 doses will be shipped to Europe this year and the company is in talks with 47 other nations including in…
Celltrion presents data for COVID-19 monoclonal antibody treatment candidate CT-P59
It demonstrated promising safety, tolerability, antiviral effect, and efficacy profile of CT-P59 in patients with mild symptoms of…
South Korea pharma Celltrion’s COVID test gets US emergency use authorisation
South Korea’s Celltrion said on Monday it has received emergency use authorisation (EUA) from the US Food & Drug…
Celltrion says COVID-19 drug shows drop in viral load in animal testing
Celltrion has research experience with other types of coronavirus conditions such as Middle East Respiratory Syndrome (MERS)